top of page
Search

New Patent in China

Updated: May 5



Qaelon Medical is proud to announce the granting of a for our life-saving platform for real-time detection of surgical leaks. This achievement expands our strong patent portfolio, which already covers the EU, US and Japan, further solidifying our position in surgical leak detection.


This milestone strengthens Qaelon's global intellectual property portfolio and reflects our efforts to set a new standard of care in surgical leak detection, combining advanced data analysis with proprietary algorithms. The recognition of our technology in the Chinese market marks an important step in expanding our reach and impact worldwide.


We remain dedicated to advancing smarter, safer surgery and are excited to bring our innovative solutions to more patients and healthcare providers globally.




 
 
 

Recent Posts

See All
Bringing Qaelon’s voice to LSI Europe 2025

CEO, Liam J. Burns, will speak at LSI Europe 2025 in London on the panel: “Pre-clinical Perspectives: Navigating the Investor and Regulatory Landscape Before First in Human.”

 
 
 

Comments


Note: Qaelon Medical products are currently under development, have not been cleared by the FDA, and are not yet available for commercial sale in the United States or Europe.

Qaelon Medical, IHU, 1 Place de l’Hôpital

67091 Strasbourg, France

Email: yee-ying.douchamps@qaelonmedical.com

  • LinkedIn

© 2025 Qaelon Medical

bottom of page